SCHEMBL15314769

SCHEMBL15314769

O=Nc1c(CN2CCCC2c2ccccn2)ccn(Cc2ccccc2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
VEGFA P15692 5/20 0.46
EGLN1 Q9GZT9 5/20 0.46
HDAC1 Q13547 1/20 0.45
LMNA P02545 1/20 0.41
CXCR4 P61073 3/20 0.40
POLB P06746 2/20 0.40
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
GNRHR P30968 1/20 0.35
CNR1 P21554 2/20 0.35
CNR2 P34972 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30274428 0.86 EGLN1 (0.63) VEGFAEGLN1HDAC1LMNACXCR4
SCHEMBL277774 0.86 EGLN1 (0.63) VEGFAEGLN1HDAC1LMNACXCR4
SCHEMBL17340661 0.73 VEGFA (0.57) VEGFAEGLN1CXCR4ALDH1A1
SCHEMBL17340697 0.73 VEGFA (0.67) VEGFAEGLN1HDAC1LMNAPOLB
SCHEMBL17340662 0.71 VEGFA (0.49) VEGFAEGLN1ALDH1A1SMN1; SMN2
SCHEMBL15314777 0.69 CNR2 (0.42) VEGFAEGLN1LMNAKDM4EALDH1A1
SCHEMBL21516685 0.69 CXCR4 (0.48) HDAC1LMNACXCR4POLBKDM4E
SCHEMBL17340685 0.68 EGLN1 (0.50) VEGFAEGLN1ALDH1A1
SCHEMBL15314775 0.67 KMT2A (0.47) VEGFAEGLN1LMNAPOLBKDM4E
SCHEMBL16603023 0.67 CYP1A2 (0.40) VEGFAEGLN1POLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2952192-A1 Prolyl hydroxylase inhibitors Aerpio Therapeutics Inc. (US) 2015-12-09 EP disclosed
EP-2649998-B1 Prolyl hydroxylase inhibitors AERPIO THERAPEUTICS INC (US) 2015-03-04 EP disclosed
EP-2649998-A1 Prolyl hydroxylase inhibitors Aerpio Therapeutics Inc. (US) 2013-10-16 EP disclosed